Centralized Patient Monitoring System Market Value Anticipated To Reach US$ 26 Bn By 2027: Acumen Research and Consulting

Ads

You May Also Like

Hemispherx Reports 2018 Third Quarter and First Nine Months Financial Results

OCALA, Fla., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American:  HEB) ...

Leap Therapeutics Announces Pricing of $14 Million Public Offering of Common Stock

CAMBRIDGE, Mass., March 23, 2018 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology ...